Glucagon Like Peptide-1 (GLP-1) Agonists Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4095814
- 102 Pages
- November 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Glucagon Like Peptide-1 (GLP-1) Agonists market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Glucagon Like Peptide-1 (GLP-1) Agonists market segmented into
Pharmaceutics & Biomedicine Industry
Lactobionic Acid Powder
Based on the end-use, the global Glucagon Like Peptide-1 (GLP-1) Agonists market classified into
Pharmaceutics & Biomedicine Industry
Cosmetic Industry
Food Industry
Chemical Industry
Based on geography, the global Glucagon Like Peptide-1 (GLP-1) Agonists market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Reliable Biopharmaceutical
Global Lactobionic Acid
Bio-sugars Technology
Manus Aktteva Biopharma
Carbosynth
Shanghai Hongbang Medical Technology
BOC Sciences
Haohua Group
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL GLUCAGON LIKE PEPTIDE-1 (GLP-1) AGONISTS INDUSTRY
2.1 Summary about Glucagon Like Peptide-1 (GLP-1) Agonists Industry
2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Market Trends
2.2.1 Glucagon Like Peptide-1 (GLP-1) Agonists Production & Consumption Trends
2.2.2 Glucagon Like Peptide-1 (GLP-1) Agonists Demand Structure Trends
2.3 Glucagon Like Peptide-1 (GLP-1) Agonists Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Lactobionic Acid Solution
4.2.2 Lactobionic Acid Powder
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Pharmaceutics & Biomedicine Industry
4.3.2 Cosmetic Industry
4.3.3 Food Industry
4.3.4 Chemical Industry
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Lactobionic Acid Solution
5.2.2 Lactobionic Acid Powder
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Pharmaceutics & Biomedicine Industry
5.3.2 Cosmetic Industry
5.3.3 Food Industry
5.3.4 Chemical Industry
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Lactobionic Acid Solution
6.2.2 Lactobionic Acid Powder
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Pharmaceutics & Biomedicine Industry
6.3.2 Cosmetic Industry
6.3.3 Food Industry
6.3.4 Chemical Industry
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Lactobionic Acid Solution
7.2.2 Lactobionic Acid Powder
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Pharmaceutics & Biomedicine Industry
7.3.2 Cosmetic Industry
7.3.3 Food Industry
7.3.4 Chemical Industry
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Lactobionic Acid Solution
8.2.2 Lactobionic Acid Powder
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Pharmaceutics & Biomedicine Industry
8.3.2 Cosmetic Industry
8.3.3 Food Industry
8.3.4 Chemical Industry
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Lactobionic Acid Solution
9.2.2 Lactobionic Acid Powder
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Pharmaceutics & Biomedicine Industry
9.3.2 Cosmetic Industry
9.3.3 Food Industry
9.3.4 Chemical Industry
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Reliable Biopharmaceutical
10.1.2 Global Lactobionic Acid
10.1.3 Bio-sugars Technology
10.1.4 Manus Aktteva Biopharma
10.1.5 Carbosynth
10.1.6 Shanghai Hongbang Medical Technology
10.1.7 BOC Sciences
10.1.8 Haohua Group
10.2 Glucagon Like Peptide-1 (GLP-1) Agonists Sales Date of Major Players (2017-2020e)
10.2.1 Reliable Biopharmaceutical
10.2.2 Global Lactobionic Acid
10.2.3 Bio-sugars Technology
10.2.4 Manus Aktteva Biopharma
10.2.5 Carbosynth
10.2.6 Shanghai Hongbang Medical Technology
10.2.7 BOC Sciences
10.2.8 Haohua Group
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Glucagon Like Peptide-1 (GLP-1) Agonists Product Type Overview
2.Table Glucagon Like Peptide-1 (GLP-1) Agonists Product Type Market Share List
3.Table Glucagon Like Peptide-1 (GLP-1) Agonists Product Type of Major Players
4.Table Brief Introduction of Reliable Biopharmaceutical
5.Table Brief Introduction of Global Lactobionic Acid
6.Table Brief Introduction of Bio-sugars Technology
7.Table Brief Introduction of Manus Aktteva Biopharma
8.Table Brief Introduction of Carbosynth
9.Table Brief Introduction of Shanghai Hongbang Medical Technology
10.Table Brief Introduction of BOC Sciences
11.Table Brief Introduction of Haohua Group
12.Table Products & Services of Reliable Biopharmaceutical
13.Table Products & Services of Global Lactobionic Acid
14.Table Products & Services of Bio-sugars Technology
15.Table Products & Services of Manus Aktteva Biopharma
16.Table Products & Services of Carbosynth
17.Table Products & Services of Shanghai Hongbang Medical Technology
18.Table Products & Services of BOC Sciences
19.Table Products & Services of Haohua Group
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Glucagon Like Peptide-1 (GLP-1) Agonists Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
